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Memory T cells are heterogeneous in phenotype and function. In this issue of Immunity, Newell et al. (2012)
use a new flow cytometry platform to show that the functional heterogeneity of the human T cell compartment
is even greater than previously thought.Naive T cells differentiate when they
encounter an antigen for which their
T cell receptor (TCR) is specific along
with the correct set of signals from cyto-
kines and costimulatory ligands. In an
explosive burst of clonal proliferation,
they develop into effector lymphocytes,
a small fraction of which persists as
memory lymphocytes. Studies over many
years have shown that the resulting
populations of effector and memory lym-
phocytes formed in the process are ex-
tremely heterogeneous in terms of pheno-
type, function, and longevity (Kaech and
Wherry, 2007).
In addition to phenotypic markers that
distinguish between subsets of effector
andmemory T cells, they can also be sub-
divided on the basis of functional special-
ization. Formative observations by Mos-
mann and Coffman revealed that some
CD4+ T cell clones secreted mutually ex-
clusive patterns of cytokines (Mosmann
et al., 1986). This identification of T helper
1 (Th1) and Th2 cell lineages in the CD4+
T cell compartment paved the way for
the identification of a profusion of func-
tionally distinct CD4+ T cell states
(McKinstry et al., 2010). Collectively, this
work suggests that there is enormous
heterogeneity in the phenotype and func-
tion of individual cells within the T cell
compartment. Understanding the number
and nature of the diverse states generated
when T cells encounter cognate antigen
has been a central goal in immunology
for nearly four decades.
Immunologists who study T cell differ-
entiation have the good fortune to work
with a cell type that exists in single-cell
suspension, a fact that has enabled flow
cytometry to catalog easily the pheno-
types present in a heterogeneous popula-
tion with single-cell resolution. Over the10 Immunity 36, January 27, 2012 ª2012 Elsyears, improvements in reagents and
technologies have meant that the expres-
sion level of a dozen or more proteins on
each cell can be deconvolved by stain-
ing cells with monoclonal antibodies
labeled with fluorochromes whose emis-
sion spectra can be individually resolved
(Perfetto et al., 2004). However, as im-
pressive as these technologies have
become, they have started to bump into
a ceiling in the number of labeled anti-
bodies that can be used to costain a
population of cells because of the inevi-
table overlap of excitation and emis-
sion spectra from closely related fluoro-
chromes. In addition, it has become
challenging to visualize the resulting data
sets at the level of individual markers:
inspecting the pair-wise expression of
17 markers on a population of cells, for
instance, takes 153 flow plots and con-
siderable patience. As a result of these
two limitations, it has become difficult to
probe the phenotypic and functional com-
plexity of the T cell compartment beyond
the states already known.
In this issue of Immunity, Newell et al.
(2012) have overcome these barriers and
deeply interrogated the diversity of the
CD8+ T cell compartment in humans by
using a flow cytometry technique based
on single-cell mass spectrometry (Cytom-
etry by Time-Of-Flight [CyTOF]). This plat-
form allows many more antibody species
to be resolved—25 in this case—because
there is essentially no overlap in themass:
charge ratio of the isotopes used to label
the antibodies, unlike the emission
spectra of fluorochromes. In addition,
they showcase a new approach to visual-
izing multiparameter flow cytometry.
Traditionally, immunologists have pre-
sented flow cytometry data in variations
of a scatter plot in which the axes repre-evier Inc.sent staining intensities of pairs of anti-
body markers. However, because hu-
mans do a poor job at conceptualizing
more than three dimensions, Newell
et al. (2012) have adopted data analysis
and visualization approaches developed
to handle other complex data set such
as those generated by genome-wide
gene expression profiling. They applied
an established technique called principal
components analysis (PCA) to collapse
a large number of parameters down to
a smaller number of parameters to aid
visualization of the data (Figure 1). PCA
decomposes the data into vectors or
components, each of which is an amal-
gam of the values of the staining intensi-
ties of several markers that vary most
across the data set as a whole, weighted
according to their variance. Using varia-
tion as a criterion to collapse the data
down to a smaller number of parameters
is a helpful approach because measures
(such as staining intensities or transcript
abundance) that are constant across all
samples or cells aren’t likely to be of
interest. The advantage is that often
two or three components are sufficient
to capture the majority of variation in the
data set and this allows the ‘‘shape’’ of
the data to be visualized in human-friendly
two or three dimensions again. The disad-
vantage is the loss of granular under-
standing how each marker is expressed
by each cell.
They use this approach tomake several
important observations. First, they show
that the heterogeneity of the T cell
compartment in humans is remarkable.
Although they used surface markers such
as CD45RA or CD62L, which have es-
sentially dichotomous distributions in the
T cell pool and which might be expected
to sharply demarcate populations of cells,
Figure 1. Reducing Dimensionality with Principal Components Analysis
Principal component analysis (PCA) is a mathematical procedure that transforms a number of parameters
into a smaller number of uncorrelated variables called principal components. PCA can be used to visualize
multiparameter data sets generated by gene-expression profiling or flow cytometry. In this example, only
two parameters are shown; however, the procedure can be applied to data sets involving any number of
parameters. On the left, cells are stained with two antibodies (red and blue) against different proteins. As
shown in the middle, when analyzed by flow cytometry, each cell is described by the staining intensity of
the two antibodies (dotted lines). On the right, the first principal component (in green) is calculated as
a linear combination of the red and blue parameters that accounts for the greatest statistical variance
in the data. Each cell is now described by its projection (green dotted line) on a single direction described
by the first principal component (PC1). Subsequent components are calculated in a similar way so that
each is orthogonal to the previous component. The top two or three components are often sufficient to
capture the majority of the variation in the data.
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used, it became apparent that whereas
conventional subsets of cells (naive,
central memory and effector memory)
could be readily identified, there were
also populations of cells that appear to
have shades of intermediary phenotypes
between these major clusters. This sug-
gests that the heterogeneity present in
the human T cell compartment is even
greater than that already known.
The second important point is that
the functional—as well as phenotypic—
complexity is dizzying. Newell et al. (2012)
measured nine functional parameters eli-
cited by stimulation with TCR crosslinking
or PMA and found over 200 distinct func-
tional phenotypes, i.e., subpopulations of
cells that manifested different combina-
tions of functions. One interpretation is
that these functional profiles are simply
random combinations of functional traits
exhibited by any given cell at any given
time. However, importantly, this number
of discrete functional phenotypes—as
large as it is—is smaller than that which
would be the expected result if all pos-
sible permutations of the nine functional
parameters were present (a total of 512).
This suggests that the precise combina-
tion of cytokines secreted by any one
cell may not be random but instead may
result in part from regulatory mechanisms
that specify that functional profile. This
finding is consistent with data from
another recent study that used a nanoflui-
dic device to measure a large number ofcytokines and chemokines elicited by
individual stimulated human T cells (Ma
et al., 2011). Those investigators also
found that the total number of observed
functional combinations was far below
the total possible number that would have
been observed by chance combinations
alone. In addition to these findings, Newell
et al.’s study also raises two important
questions.
The first of these questions is howmany
subsets are there in the T cell compart-
ment of humans? The answer to this
depends on a related, more complicated
question of what a subset is. As more
markers are used to interrogate cells and
the possible combinations of their expres-
sion increase, it is likely that more hetero-
geneity will be uncovered. We may reach
the theoretical limit of finding that every
cell is phenotypically and/or functionally
distinct from all others. However, some
of these differences are likely to be subtle,
and the challenge will be to determine
whether meaningful biological differences
exist between cells that occupy different
niches in marker space.
One way to infer meaningful differences
between cells in different clusters would
be if the parameters that separate them
include genes—like transcription factors
or hallmarks of pathway activation—that
are known to confer different biological
states. However, that may be practically
difficult to achieve using flow cytometry
alone because good monoclonal anti-
bodies may not be available for all infor-Immunity 3mative proteins. Using single-cell mea-
sures of gene-expression may provide
a supplemental approach to probe diver-
sity in a population of T cells (Flatz et al.,
2011).
The second question is what is all
this heterogeneity for? It is convenient to
think about functional specialization in
the immune system from the point of
view that one functional phenotype equa-
tes to one task. For instance, Th1 cells
are well suited to combating intracellular
pathogens, whereas a Th17 cell functional
profile appears to be necessary to defend
against extracellular pathogens like fungi
(Milner et al., 2008). However, in an envi-
ronment in which the host must con-
stantly and flexibly respond to a vast array
of pathogens, devoting the energy to
creating custom subsets of T cells for
pathogens as yet unseen is unlikely to
be useful.
In clonal populations of unicellular
organisms, the greatest flexibility of the
population as a whole to changing envi-
ronmental circumstances is afforded by
creating phenotypic diversity in individual
members through stochastic fluctua-
tions in gene expression (Raj and van
Oudenaarden, 2008). Some data suggest
that similar mechanisms exist in T cells
(Feinerman et al., 2008). Seeding diversity
into a clonal expansion of T cells may
equip the host with themost wide-ranging
set of responses to pathogens. The
output of a T cell response could therefore
be viewed as the summed total of indi-
vidual contributions of many responding
T cells with a wide gamut of different func-
tional profiles. This idea is supported by
Newell et al.’s finding that T cells specific
to different epitopes of the same virus
occupy different niches of expression
space. The extent to which the immense
number of T cell functional phenotypes re-
vealed by Newell et al. is created through
deterministic or stochastic mechanisms
remains to be seen.
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